30 participants
A Study of Lorlatinib in Advanced ALK and ROS1 Rearranged Lung Cancer With CNS Metastasis in the Absence of Measurable Extracranial Lesions
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2021-03-09
- Start Date:
- 2016-10-31
- Completion:
- 2022-01-31
Conditions
- Non-Small Cell Lung Cancer (NSCLC)
Interventions
- DRUG
No Results Yet